External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Ophthalmology ARVO 2021
Roche and Genentech at

ARVO 2021

May 01 - May 07
Virtual
arvo.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Highlights
Coming soon
10:15 AM
Duration 11mins Virtual
Efficacy, durability, and safety of faricimab▼ in diabetic macular edema (DME): one-year results from the phase 3 YOSEMITE and RHINE trials
Wells JA, Wykoff CC, Willis JR, Haskova Z, Lin H, Silverman D, Adamis AP, Ives J, Abreu F, Basu K, Tadayoni R
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:15 AM
Duration 9mins Virtual
Multi-modal Geographic Atrophy Lesion Growth Rate Prediction using Deep Learning
Yang Q, Anegondi N, Steffen V, Rabe C, Ferrara D, Gao S
Ophthalmology | Geographic Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:15 AM
Duration 10mins Virtual
Automated screening of moderately severe and severe nonproliferative diabetic retinopathy from 7 fields color fundus photographs (7F-CFP) using Deep Learning (DL)
Benmansour F, Yang Q, Damopoulos D, Anegond N, Neubert A, Novosel J, Armendariz B, Ferrara D
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:30 PM
Duration 7mins Virtual
Pharmacokinetic profile of the Port Delivery System with ranibizumab▼ (PDS) in the phase 3 Archway trial
Campochiaro P, Gune S, Maia M, Ding HT, Maass K
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 6mins Virtual
Prediction of ranibizumab▼ injection frequency in patients with macular edema due to retinal vein occlusion during as-needed dosing period of BRAVO and CRUISE Phase 3 trials
Li Y, Steffen V, Benmansour F, Friesenhahn M, Haskova Z
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 11mins Virtual
Simultaneous Ang-2/VEGF-A inhibition prevents subretinal fibrosis progression in preclinical mouse models of choroidal neovascularization (CNV)
Linder M, Foxton R, Uhles S, Revelant F, Lazendic M, Canonica J, Garcia Garrido M, Westenskow P
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins Virtual
Prediction of best-corrected visual acuity (BCVA) from color fundus photography (CFP) using deep learning (DL)
Kawczynski M, Anegondi N, Yang Q, Willis J, Bengtsson T, Gao S, Dai J
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:45 PM
Duration 7mins Virtual
The Port Delivery System with ranibizumab (PDS)—a new paradigm for long-acting retinal drug delivery
Stewart J, Tam T, Horvath J, Rea J, Barteselli G, Ranade S
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:15 AM
Duration 11mins Virtual
Faricimab▼ in Neovascular Age-Related Macular Degeneration: 1-Year Efficacy, Safety, and Durability in the Phase 3 TENAYA and LUCERNE Trials
Khanani A, Heier J, Quezada Ruiz C, Lin H, Silverman D, Brittain C, Ives J, Swaminathan B, Basu K, Wong T
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 11mins Virtual
Characterization of real-world progression from non-proliferative to proliferative diabetic retinopathy in patients with diabetes
Babiuch A, Gale S, Conti T, McLaughlin L, Kalur A, Gan R, Iyer A, Ferrara D, Greenlee T, Spicer G, Muste J, Hopkins J, Singh R
Ophthalmology | Diabetic Retinopathy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

Sign up or login to unlock the full suite of MEDICALLY features
2021 ARVO Annual Meeting In-depth Report
Springer Healthcare
Open asset

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.